Amelioration from the ocular irritant Capsaicin: development and assessment of a Capsazepine in situ gel system for ocular delivery

References

• Krishnatreyya H, Hazarika H, Saha A, et al. Capsaicin, the primary constituent of pepper sprays and its pharmacological effects on mammalian ocular tissues. Eur J Pharmacol. 2018;819:114-121.
   Google Scholar
• Krishnatreyya H, Hazarika H, Saha A, et al. Fundamental pharmacological expressions on ocular exposure to capsaicin, the principal constituent in pepper sprays. Sci Rep. 2018;8(1):12153. .
   PubMedGoogle Scholar
• Deane-Drummond A. Riot Control. Royal United Services Institute for Defence Studies: London;1975.
   Google Scholar
• Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;23(6653):816–824. .
   Google Scholar
• Urban L, Dray A. Capsazepine, a novel capsaicin antagonist, selectively antagonizes the effects of capsaicin in the mouse spinal cord in vitro. Neurosci Lett. 1991;134(1):9–11.
   PubMed Web of Science ®Google Scholar
• Carnevale V, Tibor R. TRPV1: a target for rational drug design. Pharmaceuticals. 2016;9(3):52.
   Web of Science ®Google Scholar
• Appendino G, Muñoz E, Fiebich BL. TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists. Expert Opin Ther Pat. 2003;13(12):1825–1837.
   Web of Science ®Google Scholar
• Gao ZG, Lee MK, Oh U, et al. Determination of capsazepine in rat plasma by high performance liquid chromatography. J Liq Chromatogr Related Technol. 2000;23(12):1865–1872. .
   Web of Science ®Google Scholar
• Gupta H, Jain S, Mathur R, et al. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv. 2007;14(8):507–515. .
   PubMed Web of Science ®Google Scholar
• Gurny R, Ibrahim H, Buri P. In: The development and use of in situ formed gels triggered by pH. In: Biopharmaceutics of Ocular Drug Delivery. Edman Y, ed. Boca Raton, Florida: CRC press; 1993. p. 81–90.
   Google Scholar
• Madan M, Bajaj A, Lewis S, et al. In situ forming polymeric drug delivery systems. Indian J Pharm Sci. 2009;71(3):242. .
   PubMed Web of Science ®Google Scholar
• Al Khateb K, Ozhmukhametova EK, Mussin MN, et al. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery. Int J Pharm. 2016;502(1–2):70–79. .
   PubMed Web of Science ®Google Scholar
• Gilbert JC, Richardson JL, Davies MC, et al. The effect of solutes and polymers on the gelation properties of Pluronic F-127 solutions for controlled drug delivery. J Control Release. 1987;5(2):113–118. .
   Google Scholar
• Başaran E, Yazan Y. Ocular application of chitosan. Expert Opin Drug Delivery. 2012;9(6):701–712.
   PubMed Web of Science ®Google Scholar
• Alonso MJ, Sánchez A. The potential of chitosan in ocular drug delivery. Journal of Pharmacy and Pharmacology. 2003;55(11):1451–1463.
   PubMed Web of Science ®Google Scholar
• Vadnere M, Amidon G, Lindenbaum S, et al. Thermodynamic studies on the gel-sol transition of some pluronic polyols. Ophthalmology. 1984;28:113–117.
   Google Scholar
• Felt O, Furrer P, Mayer JM, et al. Topical use of chitosan in ophthalmology: tolerance, assessment and evaluation of precorneal retention. Int J Pharm. 1999;180(2):185–193. .
   PubMed Web of Science ®Google Scholar
• Felt O, Carrel A, Baehni P, et al. Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. J Ocul Pharmacol Ther. 2000;16(3):261–270. .
   PubMed Web of Science ®Google Scholar
• Hanna C, Fraunfelder FT, Meyer SM. Effects of dimethyl sulfoxide on ocular inflammation. Ann Ophthalmol. 1977;9(1):61–65.
   PubMedGoogle Scholar
• Hussain A, Haque MW, Singh SK, et al. Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II. Drug Deliv. 2016;23(4):1242–1253. .
   PubMed Web of Science ®Google Scholar
• Aiyalu R, Govindarjan A, Ramasamy A. Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model. Braz J Pharm. 2016;52(3):493–507.
   Google Scholar
• Tan SZ, Mullard G, Hollywood KA, et al. Characterisation of the metabolome of ocular tissues and post-mortem changes in the rat retina. Exp Eye Res. 2016;149:8–15.
   PubMed Web of Science ®Google Scholar
• Fathalla ZM, Vangala A, Longman M, et al. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies. Eur J Pharm Biopharm. 2017;114:119–134. .
   PubMed Web of Science ®Google Scholar
• OECD, Organization for economic cooperation and development, OECD guideline for the testing of chemicals. Test No. 405: acute Eye Irritation/ Corrosion, 2012 Oct 2. Available from:https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg405-2012-508.pdf (2012).
   Google Scholar
• Luo LJ, Lai JY. Epigallocatechin gallate-loaded gelatin-g-poly (N-isopropylacrylamide) as a new ophthalmic pharmaceutical formulation for topical use in the treatment of dry eye syndrome. Sci Rep. 2017;7(1):9380.
   PubMedGoogle Scholar
• Slameňová D, Horváthová E, Wsólová L, et al. Investigation of anti-oxidative, cytotoxic, DNA-damaging and DNA-protective effects of plant volatiles eugenol and borneol in human-derived HepG2, Caco-2 and VH10 cell lines. Mutat Res Genet Toxicol Environ Mutagen. 2009;677(1–2):46–52. .
   PubMed Web of Science ®Google Scholar
• Velpandian T, Gupta P, Ravi AK, et al. Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models. BMC Compl Altern Med. 2013;13(1):1–12
   PubMedGoogle Scholar
• Lo YL, Hsu CY, Lin HR. pH-and thermo-sensitive pluronic/poly (acrylic acid) in situ hydrogels for sustained release of an anticancer drug. J Drug Target. 2013;21(1):54–66.
   PubMed Web of Science ®Google Scholar
• Costantino HR, Firouzabadian L, Hogeland K, et al. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm Res. 2000;17(11):1374–1382. .
   PubMed Web of Science ®Google Scholar
• Eakins KE, Whitelocke RAF, Bennett A, et al. Prostaglandin-like activity in ocular inflammation. Br Med J. 1972;3(5824):452–453. .
   PubMedGoogle Scholar
• Doucette LP, Walter MA. Prostaglandins in the eye: function, expression, and roles in glaucoma. Ophthalmic Genet. 2017;38(2):108–116.
   PubMed Web of Science ®Google Scholar